Bodybuilders and others who want to increase muscle growth use Dindolyl Methane (or DIM). Recent studies have shown that DIM could pose health risks. DIM can cause liver damage if consumed in excessive amounts. Another risk is kidney damage, which can lead to kidney failure. The long-term health risks of DIM have many bodybuilders and athletes ask the question: should I use supplements with DIM?

To increase testosterone production, most people take a diindolylmethane supplement. Testosterone has been shown to act as an androgen, meaning that it can cause hormonal changes in tissues. Studies have proven DIM to mimic the effects both of testosterone and other hormones. Some manufacturers have added diindolylmethane (DIM) to their products to increase their popularity in male circles because men produce more testosterone than women. The theory is that men react to a product that mimics the effects of testosterone naturally produced.

Many companies market DIM as a tumor suppressor. Diindolylmethane is a fact that it does reduce the growth of tumors in laboratory animals, however the animals were injected with the drug, not orally. To achieve the same result in humans, diindolylmethane has to be consumed in high doses over a long period of time. Also, although the animals studied remained cancer free for several years but all of them suffered from liver disease at some point, probably due to the excessive diindolylmethane being present in their bodies. A doctor can give you more information about the way DIM functions within the body.

According to the US National Institute of Environmental Health Safety and Security, the only way to prove that DIM is effective in treating breast cancer is to conduct an experiment where cells from healthy breast cancer cells are exposed to large doses of diindolylmethane over a prolonged period of time. As with any chemical, there are both pros and cons to using it. Pros include the capability to mimic hormones. This allows you to make insulin that inhibits cancer cell growth. The negatives include the fact that diindolylmethane can also produce a potentially harmful chemical called DMSO. Learn more about what does diindolylmethane do here.

One of the most commonly used claims for diindolylmethane to be treatment for various health issues is that it functions as a natural, anti-fungal, antibacterial and anti-cancer drug. The National Institute of Health, in their exhaustive review of the supporting evidence found no evidence to support these claims. According to the Institute of Chemical Technology, there were no experiments performed to support this claim. In an in-depth examination of the safety profile of the firestone the Institute of Chemical Safety concluded that the evidence of pharmaceutical companies about the benefits for humans of diindolylmethane was not substantiated.

In a May 2021 edition of the Journal of Toxicology and Environmental Health, van der Goes, and colleagues. Van der Goes, and. identified the potential risks of diindolylmethane, which includes allergic reactions to the skin, asthma attacks as well as dizziness, headaches and respiratory problems. They also stated that the recommended daily allowance for this chemical is 0.2 milligrams, or about one tenth of a teaspoon. It is not clear what the concentration level is when compounded with other substances. Because this substance hasn’t been thoroughly tested, it cannot be considered to be safe at any level.

The abstract of the view demonstrates that the use of diindolylmethane for cancer treatment is based on the notion that intracellular inhibition of pyruvate metabolism by flavenoids is a possibility to block and prevents accumulation of oxalates and pyruvate metabolites in renal tubule cells. The drug metabiplicate toxicology studies have not shown that this chemical can cause overdose. The Food and Drug Administration approved this substance as a prescribed drug in June 1996. According to the FDA the company that makes firestone tincture is in the process of completing two major clinical trials – one in Europe and the other in the United States.

The abstract of the view also demonstrates that diindolylmethane’s use in cancer treatment is based on the concept of inhibiting intracellular inhibition through flavenoids that regulate pyruvate metabolism and thus preventing the accumulation of adenine and oxalates in renal tubule cells. However, the drug metabiplicate toxicity studies did not provide evidence convincing that consumption of this chemical can cause an overdose. The Food and Drug Administration approved this substance as a prescription drug in June 1996. According to the FDA the company that makes firestone Tincture is currently completing two major trials in Europe and the United States. According to FDA, the FDA states that the maker of firestone Tincture is completing two major trials in Europe as well as one in the United States.